Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Tg Therapeutics Inc (TGTX)

361 + Investors. Track Smart Money conviction in TGTX. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +13
Streak
2Q ▲
Buyers last Q
56%

Smart Money Signals — TGTX

Based on 363 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added TGTX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (98% of max)

98% of all-time peak
363 hedge funds hold TGTX right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
〰️

Stable — ownership unchanged year-over-year

fund count last 6Q
The number of hedge funds holding TGTX is almost the same as a year ago (-6 funds, -2% change). No significant rush to buy or sell — institutional backing is holding steady.
🟡

Slight buying edge — 56% buying

208 buying165 selling
Last quarter: 208 funds bought or added vs 165 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
➡️

Steady new buyers — ~69 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 44 → 45 → 64 → 69. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

47% of holders stayed for 2+ years

■ 47% conviction (2yr+) ■ 30% medium ■ 23% new
171 out of 363 hedge funds have held TGTX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares +3%, value -55%

Value
-55%
Shares
+2%
Last quarter: funds added +3% more shares while total portfolio value only changed -55%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📈

Growing discovery — still being found

85 → 44 → 45 → 64 → 69 new funds/Q
New funds entering each quarter: 44 → 45 → 64 → 69. A growing number of institutions are discovering TGTX each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Deep conviction — 58% of holders stayed 2+ years

■ 58% veterans ■ 18% 1-2yr ■ 24% new
Of 382 current holders: 222 (58%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
✅

Strong quality — 39% AUM from major funds

39% from top-100 AUM funds
53 of 363 holders rank in the top 100 by AUM, accounting for 39% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
3.5
out of 10
Low Exit Risk
Exit risk score 3.5/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — TGTX

In 2026 Q1, 208 hedge funds were net buyers of TGTX (69 opened a new position, 139 added to an existing one), while 165 reduced or exited (109 trimmed, 56 sold completely) — a 56% buyer ratio, indicating a slight buying edge. Net buying has persisted for two consecutive quarters, a positive momentum signal. 39% of total institutional value in TGTX is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +13 funds (more new holders than closures). Total institutional holders: 363.

Hedge Fund Ownership: TGTX

How many hedge funds hold TGTX — quarterly history vs. share price
Quarterly hedge fund ownership of TGTX vs. share price

Market Analysis: TGTX

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: TGTX

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Tg Therapeutics Inc (TGTX) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much TGTX has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 79d ago
TGTX
+52.1%
XLV
+2.1%

TGTX outperformed XLV by +50.0% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 34d ago
TGTX
+27.9%
XLV
+3.2%

Since the filing became public, TGTX outperformed XLV by +24.7% .

Interpretation: The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

30 top-rated funds 3 high-conviction
Consensus
6.5
/ 10
breadth
×
Elite
2.7
/ 10
conviction
Hedge Fund Positioning: TGTX
361 + Investors

Track Smart Money conviction in TGTX. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 361 350 3.14%
13F Shares 110M 107M 2.55%
Total Value $3.59B $8.02B -55.2%
New Positions 67 64 +3
Increased Positions 132 129 +3
Closed Positions 56 58 -2
Reduced Positions 107 109 -2
Total Calls 12 11 9.09%
Total Puts 10 9 11.11%
PUT/CALL Ratio 0.83 0.82 Neutral

Statistics: TGTX

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

361 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in TGTX. Verified SEC 13F-HR filings.

QUARTER:
Top 25 TGTX holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Occam Crest Management LP 11.63% 577,000 $19.2M
2 Act Capital Management, LLC 6.50% 249,025 $8.3M
3 M28 Capital Management LP 5.46% 88,354 $2.9M
4 Soleus Capital Management, L.P. 5.42% 4,029,319 $133.9M
5 Opaleye Management Inc. 2.34% 535,000 $17.8M
6 Knott David M Jr 1.78% 90,001 $3.0M
7 Penn Capital Management Company, LLC 1.40% 541,960 $18.0M
8 Diadema Partners LP 1.17% 206,928 $6.9M
9 683 Capital Management, LLC 1.02% 590,000 $19.6M
10 Quantum Private Wealth, LLC 1.02% 98,908 $3.3M
11 Iridian Asset Management LLC/Ct 1.01% 75,289 $2.5M
12 Cornerstone Select Advisors, LLC 0.98% 46,908 $1.6M
13 Bridge City Capital, LLC 0.83% 90,634 $3.0M
14 Persistent Asset Partners Ltd 0.66% 53,080 $1.8M
15 Neo Ivy Capital Management 0.53% 60,833 $2.0M
16 Hood River Capital Management LLC 0.52% 1,569,171 $52.1M
17 Congress Asset Management Co 0.52% 2,168,081 $72.0M
18 Westview Management dba Westview Investment Advisors 0.51% 29,261 $972K
19 Braidwell LP 0.40% 358,800 $11.9M
20 Yorktown Management & Research Co Inc 0.38% 13,700 $455K
21 NJ State Employees Deferred Compensation Plan 0.37% 91,600 $3.3M
22 Avaii Wealth Management, LLC 0.34% 29,105 $967K
23 PSP Research LLC 0.31% 13,000 $432K
24 CWC Advisors, LLC. 0.30% 19,081 $634K
25 Virtus Investment Advisers, LLC 0.25% 26,930 $895K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Tg Therapeutics Inc (TGTX)

What does the Smart Money Trend signal show for TGTX?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added TGTX than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for TGTX?

Slight buying edge — 56% buying: Last quarter: 208 funds bought or added vs 165 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for TGTX holders?

Strong quality — 39% AUM from major funds: 53 of 363 holders rank in the top 100 by AUM, accounting for 39% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held TGTX?

47% of holders stayed for 2+ years: 171 out of 363 hedge funds have held TGTX for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Tg Therapeutics Inc (TGTX) following the 2026 Q1 hedge fund 13F filings?

As of today, TGTX has moved +27.9% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of +24.7%. Since the quarter end (March 31, 2026), TGTX has gained +52.1% vs +2.1% for XLV. The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →